Refractory Neuroblastoma
Drug | Drug Name | Drug Description |
---|---|---|
DB00853 | Temozolomide | An alkylating agent used to treat glioblastoma multiforme and refractory anaplastic astrocytoma. |
DB01030 | Topotecan | An antineoplastic agent used to treat ovarian cancer, small cell lung cancer, or cervical cancer. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00853 | Temozolomide | DNA | target |
DB00853 | Temozolomide | Serum albumin | carrier |
DB00853 | Temozolomide | Alpha-1-acid glycoprotein 1 | carrier |
DB00853 | Temozolomide | P-glycoprotein 1 | transporter |
DB00853 | Temozolomide | ATP-binding cassette sub-family G member 2 | transporter |
DB01030 | Topotecan | DNA topoisomerase I, mitochondrial | target |
DB01030 | Topotecan | DNA topoisomerase 1 | target |
DB01030 | Topotecan | ATP-binding cassette sub-family G member 2 | transporter |
DB01030 | Topotecan | P-glycoprotein 1 | transporter |
DB01030 | Topotecan | DNA | target |
DB01030 | Topotecan | Multidrug and toxin extrusion protein 1 | transporter |
DB01030 | Topotecan | Multidrug and toxin extrusion protein 2 | transporter |